Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI tool automates liver tumor detection and monitoring

2.

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

3.

For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.

4.

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

5.

Overdosing on Chemotherapy: A Single Gene Test Could Prevent Hundreds of Deaths Annually.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot